# Resveratrol in Knee Osteoarthritis

> **NCT02905799** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 142 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** oral resveratrol
- **DRUG:** oral placebo

## Key facts

- **NCT ID:** NCT02905799
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-09
- **Primary completion:** 2022-02-09
- **Final completion:** 2022-05-12
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02905799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02905799, "Resveratrol in Knee Osteoarthritis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02905799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*